Kadimastem Valuation
| KDST Stock | ILA 1,189 14.00 1.19% |
At this time, the firm appears to be overvalued. Kadimastem secures a last-minute Real Value of 915.18 per share. The latest price of the firm is 1189.0. Our model forecasts the value of Kadimastem from analyzing the firm fundamentals such as Return On Equity of -7.35, current valuation of 38.77 M, and Shares Owned By Insiders of 53.72 % as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Kadimastem's price fluctuation is very steady at this time. Calculation of the real value of Kadimastem is based on 3 months time horizon. Increasing Kadimastem's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Kadimastem is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Kadimastem Stock. However, Kadimastem's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1189.0 | Real 915.18 | Hype 1189.0 | Naive 1260.11 |
The real value of Kadimastem Stock, also known as its intrinsic value, is the underlying worth of Kadimastem Company, which is reflected in its stock price. It is based on Kadimastem's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Kadimastem's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Kadimastem helps investors to forecast how Kadimastem stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Kadimastem more accurately as focusing exclusively on Kadimastem's fundamentals will not take into account other important factors: Kadimastem Total Value Analysis
Kadimastem is now forecasted to have takeover price of 38.77 M with market capitalization of 30.32 M, debt of 12.96 M, and cash on hands of 5.43 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Kadimastem fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
38.77 M | 30.32 M | 12.96 M | 5.43 M |
Kadimastem Asset Utilization
One of the ways to look at asset utilization of Kadimastem is to check how much profit was generated for every dollar of assets it reports. Kadimastem secures a negative usage of assets of -0.75 %, losing 0.007485 for each of assets held by the firm. Inadequate asset utilization conveys that the company is being less effective with each of assets it secures. Strictly speaking, asset utilization of Kadimastem shows how discouraging it operates for each spent on its assets.Kadimastem Ownership Allocation
Kadimastem maintains a total of 35.76 Million outstanding shares. Kadimastem holds significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.Kadimastem Profitability Analysis
Net Loss for the year was (26.27 M) with profit before overhead, payroll, taxes, and interest of 0.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Kadimastem's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Kadimastem and how it compares across the competition.
About Kadimastem Valuation
The stock valuation mechanism determines Kadimastem's current worth on a weekly basis. Our valuation model uses a comparative analysis of Kadimastem. We calculate exposure to Kadimastem's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Kadimastem's related companies.Kadimastem Ltd, a biopharmaceutical company, develops regenerative medicine therapies based on cells derived from human embryonic stem cells to treat neuro-degenerative diseases. The company was founded in 2008 and is based in Ness Ziona, Israel. KADIMASTEM operates under Biotechnology classification in Israel and is traded on Tel Aviv Stock Exchange. It employs 28 people.
8 Steps to conduct Kadimastem's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Kadimastem's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Kadimastem's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Kadimastem's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Kadimastem's revenue streams: Identify Kadimastem's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Kadimastem's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Kadimastem's growth potential: Evaluate Kadimastem's management, business model, and growth potential.
- Determine Kadimastem's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Kadimastem's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Complementary Tools for Kadimastem Stock analysis
When running Kadimastem's price analysis, check to measure Kadimastem's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kadimastem is operating at the current time. Most of Kadimastem's value examination focuses on studying past and present price action to predict the probability of Kadimastem's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Kadimastem's price. Additionally, you may evaluate how the addition of Kadimastem to your portfolios can decrease your overall portfolio volatility.
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. |